Moderna says its Covid-19 vaccine trial produced ’robust’ immune response

Moderna says its Covid-19 vaccine trial produced ’robust’ immune response

Moderna Inc. stock rose more than 16% in the extended session Tuesday after the company said its coronavirus vaccine candidate produced a ’robust’ immune-system response in all 45 patients in its early stage human trial, according to newly released data published in the peer-reviewed New England Journal of Medicine. The biotech company will begin their late-stage trial for the vaccine on July 27.

Tom A
Tom A
David
David 4 weeks

I'm sure that Bill Gates' Pervy little mouth is watering!

Bryan Shoemaker
Bryan Shoemaker 3 weeks

Why did it take 20 years for them to start working on a cure for the virus? Coronavirus the human variety has been around for a long time and the current virus is a 99% match to the previous one. The variation between the two Is normal for viruses.

Top in Business
Get the App